Release of histamine and tryptase in vivo after prolonged cutaneous challenge with allergen in humans.
The patterns of in vivo release of histamine and tryptase were determined during prolonged Ag incubation in atopic individuals, using skin chambers placed over denuded skin blister sites. However, the patterns of histamine and tryptase release over a period of up to 9 h of Ag exposure were different. Whereas rates of release of both histamine and tryptase peaked within 1 h in an Ag dose-response fashion, that of tryptase decreased progressively thereafter and was not different from buffer challenge sites from the 5th to 9th h at all concentrations of Ag tested. The rate of histamine release reached a plateau after 2 h and remained at a constant low level throughout the 3rd to 9th h of Ag incubation. Rechallenge of the sites continuously exposed to Ag with a different second Ag at the 6th h resulted in a second peak of release of both histamine and tryptase. This persistence of in vivo histamine but not tryptase release during the later time points of the cutaneous allergic response differs from what has been demonstrated in vitro with dispersed mast cells. Whether this reflects basophil participation at these time points or an as yet undetermined mechanism for release of histamine but not tryptase by mast cells is not known. These novel patterns of mediator release after prolonged Ag exposure in vivo may have clinical relevance to allergic diseases during which atopic subjects are exposed to Ag over several hours to days.
Shalit
M
M
Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia 19104.
Schwartz
L B
LB
Golzar
N
N
vonAllman
C
C
Valenzano
M
M
Fleekop
P
P
Atkins
P C
PC
Zweiman
B
B
D000328:Adult; D000485:Allergens / Q000008:administration & dosage*; D001768:Blister / Q000201:enzymology / Q000276:immunology / Q000378:metabolism; D004306:Dose-Response Relationship, Immunologic; D000939:Epitopes / Q000032:analysis; D006636:Histamine Release; D006801:Humans; D010447:Peptide Hydrolases / Q000378:metabolism*; D011058:Pollen / Q000276:immunology; D012882:Skin Tests; D013997:Time Factors
D000485:Allergens; D000939:Epitopes; D010447:Peptide Hydrolases; C023073:tosylarginine methyl ester hydrolase